Answers are grounded in this paper and cite their sources.
Percutaneous device closure of atrial septal defects (ASD) has proven to be safe and it is nowadays the standard treatment for ASDs. Immediate or late device embolization is a rare but potential complication of every attempted ASD device closure. We report a case of asymptomatic Amplatzer Septal Occluder into the left ventricular outflow tract (LVOT) detected by routine transthoracic echocardiography 3 months after successful implantation in a stable patient.
No takes yet. Share an insight, caveat, or question.
Vijiala et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: